Ask a question. Get a source-grounded answer with citations.
Based on 10 verified sources covering Thailand:
บริษัทเบสท์ริน กรุ๊ป แถลงข่าวกรณีใบรีมาร์กการนำรถเมล์เอ็นจีวีออกจากท่าเรือแหลมฉบัง [1]
Market leader sees stock price plunge 90% from peak as chairman predicts more losses Japan drugmaker zeros in on potential 'wonder pill' for psoriasis, other conditions Cases found via checkups remain 1.2% below pre-pandemic level Health tech app ope... [2]
SEOUL/TOKYO -- South Korea's Hanmi Pharmaceutical is transforming from a generics manufacturer to a maker of brand-name drugs, committing 80% of research and development funds toward branded medicine, the company's top executive told The Nikkei. [3]
PharmaceuticalsTwo Asian pharmas hold key for global supply of Oxford vaccine India's Serum aims for 400m doses in 2020; S Korea's SK Bioscience keen on exports Oxford University and AstraZeneca are tying up with Asian companies for mass production o... [4]
Stephen Givens is a partner with the corporate law firm JLX Partners in Tokyo. OpinionTime for a requiem to Japan's poison pill takeover defense Cosmo Energy's implicit surrender to Murakami marks a turning point All Cosmo Energy shareholders will b... [5]
The Department of Intellectual Property (DIP) held discussions with the Food and Drug Administration (FDA) to support the targeted development of health products. [6]
NEW YORK -- Coronavirus-fearing American shoppers have raided such stores as Costco, Walmart and Target for nonperishable foods and household supplies. [7]
TOYAMA, Japan -- The maker of Avigan is slated to receive local government help in accessing a critical ingredient, a goal in line with Japanese plans to stockpile the flu drug showing promise against the novel coronavirus. [8]
บริษัทเบสท์ริน กรุ๊ป แถลงข่าวกรณีใบรีมาร์กการนำรถเมล์เอ็นจีวีออกจากท่าเรือแหลมฉบัง
Market leader sees stock price plunge 90% from peak as chairman predicts more losses Japan drugmaker zeros in on potential 'wonder pill' for psoriasis, other conditions Cases found via checkups remain 1.2% below pre-pandemic level Health tech app ope
SEOUL/TOKYO -- South Korea's Hanmi Pharmaceutical is transforming from a generics manufacturer to a maker of brand-name drugs, committing 80% of research and development funds toward branded medicine, the company's top executive told The Nikkei.
PharmaceuticalsTwo Asian pharmas hold key for global supply of Oxford vaccine India's Serum aims for 400m doses in 2020; S Korea's SK Bioscience keen on exports Oxford University and AstraZeneca are tying up with Asian companies for mass production o
Stephen Givens is a partner with the corporate law firm JLX Partners in Tokyo. OpinionTime for a requiem to Japan's poison pill takeover defense Cosmo Energy's implicit surrender to Murakami marks a turning point All Cosmo Energy shareholders will b
The Department of Intellectual Property (DIP) held discussions with the Food and Drug Administration (FDA) to support the targeted development of health products.
NEW YORK -- Coronavirus-fearing American shoppers have raided such stores as Costco, Walmart and Target for nonperishable foods and household supplies.
TOYAMA, Japan -- The maker of Avigan is slated to receive local government help in accessing a critical ingredient, a goal in line with Japanese plans to stockpile the flu drug showing promise against the novel coronavirus.
Dr. Mandeep Dhaliwal is director of the HIV and health group at the U.N. Development Program. Dr. Osamu Kunii is chief executive of the Tokyo-based Global Health Innovative Technology Fund.
TOKYO -- Ricoh will acquire U.S.-based biotechnology startup Elixirgen Scientific as early as July in a push to turn messenger RNA technology into a core business, Nikkei has learned. Business dealsRicoh jumps into mRNA pharmaceuticals with U.S.